If You Had Invested $1,000 in Clorox a Decade Ago: A Prospective Dividend King’s Long-Term Payoff

A Decade of Dividends, a Stock That Stood Still

Clorox (NYSE: CLX | CLX Price Prediction) spent the past 10 years doing what consumer staples are supposed to do: pay reliably, raise dividends annually, and grind through cycles. The pandemic briefly turned cleaning brands into pantry essentials, sending shares above prior highs. Then came margin compression, a 2023 cyberattack, and an ambitious $580 million ERP overhaul that the company finished rolling out in winter of FY2026.

CEO Linda Rendle closed the GOJO Industries (Purell) acquisition on April 1, 2026, broadening the hygiene portfolio alongside Glad, Brita, Kingsford, Hidden Valley, and Burt’s Bees. Its quarterly dividend of $1.24 per share was paid out on May 8, 2026, raised from $1.22 a year ago.

Your $1,000 Mostly Sat There

Here’s how an investment in Clorox stock would have fared, using dividend-adjusted prices through May 7, 2026, and compared to S&P 500 returns:

• 1-Year Return: $1,000 became $706 (−29.4%). S&P 500: $1,304 (+30.4%).
• 5-Year Return: $1,000 became $597 (−40.3%). S&P 500: $1,733 (+73.3%).
• 10-Year Return: $1,000 became $940 (−6.0%). S&P 500: $3,553 (+255.3%).

The dividend did the heavy lifting. Quarterly payouts climbed from $0.77 in 2016 to $1.24 today, lifting total return well above the price-only path. Even so, a decade of compounding dividends barely kept the position whole, while the S&P 500 more than tripled. Timing punished latecomers especially: the 2020 spike to $239 looked like a runway and turned into a ceiling.

The Bull Case Hinges on the Dividend Holding

The bull case for Clorox here rests on whether the $5.45 to $5.65 adjusted EPS guidance is the trough and the 5.76% dividend yield survives intact. On the bull side: ERP disruption fades, Purell adds scale, gross margin normalizes, and a forward P/E near 13 rerates higher. Director Pierre Breber bought 5,000 shares at around $85.82 on May 5, the kind of signal one can respect. Plus, Clorox is currently on track to become a Dividend King in 2027.

The bear case grows stronger if guidance cuts keep coming. Adjusted EPS guidance has already been trimmed from $5.95–$6.30 down to $5.45–$5.65, organic sales are down roughly 9%, and the company just priced $1.5 billion in senior notes while multiple law firms circle. If EPS slips further, the payout ratio moves uncomfortably close to 100%.

The takeaway: The brands and the dividend record are too durable to dismiss at $92, but beating the S&P 500 from here would hinge on management execution rather than market beta.